Clinical Trial Update: Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated adding bevacizumab to cisplatin and etoposide in patients with previously untreated extensive-stage small cell lung cancer; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CISPLATIN (cisplatin)
• Etoposide (Etoposide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Extensive Stage Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2010-02-02